Point72 Asset Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Point72 Asset Management’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-30,427	Closed	-$9.07K	–	3007
2023 Q2	$9.07K	Buy	+30,427	New	+$9.18K	﹤0.01%	1926

Point72 Asset Management's GRNA Position: Q3 2023 in Review

Point72 Asset Management sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 30,427 shares — an estimated $9.07K sold.

Point72 Asset Management first reported a position in GRNA in Q2 2023 and held it in 1 quarter. The position peaked at $9.07K in Q2 2023. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

Point72 Asset Management reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
Point72 Asset Management sold 30,427 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $9.07K.
Point72 Asset Management first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2023 and held it in 1 quarter.
Point72 Asset Management's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $9.07K in Q2 2023.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.